About Dr. Isabelle Brock

As the President and CEO of QoLify and the nonprofit NovaCombian Research Institute, Dr. Isabelle Brock has dedicated her professional career to the research and understanding of connective tissue issues, aiming to improve the quality of life and provide access to care for her clients. 

Dr. Brock is a visiting scientist at the department of medical and molecular genetics at the IU School of Medicine where she is establishing the center of excellence for Ehlers Danlos Syndromes clinic and performing research into EDS and its comorbidities. 

As an advisor for the Centers and Networks of Excellence Program of The Ehlers-Danlos Society, she has dedicated herself to establishing networks around the globe to give patients with EDS better access to care. Dr. Brock is also a co-founder of Clinical Paradigms, a clinic for people with complex connective tissue diseases. 

Dr. Brock has spearheaded a clinic at Barberyn Reef Hospital in Beruwala, Sri Lanka. A clinic dedicated to treating complex connective tissue disease patients with a global view, combining different medical system modalities into one treatment approach. 

Dr. Brock is the chair of the Pain and Fatigue management group and a member of the Allergy, Immunology Working Group of the International Consortium on EDS and its Comorbidities. She is a member in the AHEAD Coalition (treating pediatric pain) and the ‘Breaking Down Barriers’ Initiative of the EDS Society. 

Dr. Brock currently serves as Vice-President for the Research & Study Group for EDS (GERSED) in France and is a member of the Belgian GERSED. In addition to serving as the Chief Scientific Officer at the EDS Initiative – Deutschland, where she spearheads the committee for producing the German guidelines on EDS, she is a member of the scientific committee of the Foundation for Research & Advocacy in Muscle Pain Education (FRAME) and formerly held positions as Lead Scientist at the Hospital Hotel Dieu de Paris, and at Ellasanté, Paris. 

Further education includes certification in diagnosis and treatment for Ehlers-Danlos Syndromes (EDS) from Paris Est Créteil University and certification in Ayurvedic Medicine for Medical Professionals from the Institute of Ayurveda & Alternative Medicine, University of Ruhuna, Sri Lanka. She is currently earning a degree in Acupuncture and Traditional Chinese Medicine in the Master of Science of Oriental Medicine Program at Pacific College. Further accomplishments include her having co-created and taught tele-courses on EDS for medical professionals and spearheaded the establishment of three clinics dedicated to helping patients with EDS and its comorbidities. Dr. Brock is the co-author of “Transforming Ehlers-Danlos Syndrome: A Global Vision of the Disease - The Epigenetic Revolution - Emergencies”. 

She has produced two medical devices (patent pending) for the treatment of proprioception as well as cortisol deficiencies.